SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT
批准号:
6626675
负责人:
Jonathan D. Licht
金额:
$32.23万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 2005-12-31
关键词:
Wilms' tumor cadherins cell differentiation clinical research developmental genetics enzyme activity fibroblast growth factor gene targeting genetically modified animals human subject inhibitor /antagonist laboratory mouse mitogen activated protein kinase neoplasm /cancer genetics posttranslational modifications protein tyrosine kinase tumor suppressor genes tumor suppressor proteins
中文摘要
描述:(改编自申请人摘要)
在这个建议中,我们将描述肾脏中发芽的表达,
发育,一般的鼠发育和Wilm肿瘤。我们将
表征发芽的作用机制。因此,我们将确定,如果
发芽是一种生长抑制剂,可能介导WT 1的某些作用。我们
将决定通过受体酪氨酸激酶
愚蠢的行为然后我们分离出spry的伴侣蛋白,
对发芽的分子机制有了更好的认识。为了确定
我们将在细胞中确定spry在正常和异常发育中的作用,
培养模型和转基因动物,
干扰正常的肾脏形态发生。最后,
发芽作为WT 1的目标,对肾脏发育很重要,我们将创建
使用conditiona cre-lox技术敲除动物的sprougty 1。通过
这些研究我们将描述一个令人兴奋的分子参与isgnal
转导和发育。Spry可能会为未来的战略提出目标
针对肾母细胞瘤、其他恶性肿瘤和肾脏疾病,如多囊
肾病
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract)
In this proposal we will characterize the expression of sprouty in renal
development, murine development in general and in Wilm's tumors. We will
characterize the mechanism of action of sprouty. Hence we will determine if
sprouty is a growth inhibitor which may mediate some of the effects of WT1. We
will determine at which steo in signaling through receptor tyrosine kinase
sprouty acts. We then isolate partner proteins of spry which will lead to
better idea of the molecular mechanism of sprouty. In order to determine the
role of spry in normal and aberrant development we will determine in cell
culture models and transgenic animals if engineered expression of spry
interferes with normal renal morphogenesis. Finally to provide a critical role
of sprouty as a target of WT1 important for renal development we will create
knockout animals for sprouty one using conditiona cre-lox technology. Through
these studies we will characterize an exciting molecule involved isgnal
transduction and development. Spry may present a target for future strategies
against Wilm's tumor, other malignancies and renal disorder such as polycystic
kidney disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UF Health Cancer Center Support Grant - Training Navigator Supplement
-
批准号:10892335
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
-
批准号:10717486
-
项目类别:
-
资助金额:$50.38万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
University of Florida Health Cancer Center Support Grant
-
批准号:10625750
-
项目类别:
-
资助金额:$213.5万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
Developmental Funds
-
批准号:10625759
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
Leadership, Planning, and Evaluation
-
批准号:10625761
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2023
-
负责人:Jonathan D. Licht
-
依托单位:
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
-
批准号:10666665
-
项目类别:
-
资助金额:$47.85万
-
财政年份:2022
-
负责人:Jonathan D. Licht
-
依托单位:
KDM6A mutation as an epigenetic driver of multiple myeloma
-
批准号:10229675
-
项目类别:
-
资助金额:$5.7万
-
财政年份:2020
-
负责人:Jonathan D. Licht
-
依托单位:
2019 Cancer Genetics and Epigenetics GRC/GRS
-
批准号:9754282
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2019
-
负责人:Jonathan D. Licht
-
依托单位:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
-
批准号:9330809
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:Jonathan D. Licht
-
依托单位:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
-
批准号:9759647
-
项目类别:
-
资助金额:$33.84万
-
财政年份:2016
-
负责人:Jonathan D. Licht
-
依托单位:
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
-
批准号:8866966
-
项目类别:
-
资助金额:$198.95万
-
财政年份:2015
-
负责人:Jonathan D. Licht
-
依托单位:
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer
-
批准号:8866971
-
项目类别:
-
资助金额:$52.07万
-
财政年份:2015
-
负责人:Jonathan D. Licht
-
依托单位:
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
-
批准号:9070573
-
项目类别:
-
资助金额:$207.45万
-
财政年份:2015
-
负责人:Jonathan D. Licht
-
依托单位:
UTX, MLL and Pathogenic Deregulation of Histone Methylation in Multiple Myeloma
-
批准号:8916053
-
项目类别:
-
资助金额:$5.14万
-
财政年份:2014
-
负责人:Jonathan D. Licht
-
依托单位:
UTX, MLL and Pathogenic Deregulation of Histone Methylation in Multiple Myeloma
-
批准号:8775116
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2014
-
负责人:Jonathan D. Licht
-
依托单位:
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
-
批准号:9353181
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2014
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:7754697
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:8206815
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:7583854
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma
-
批准号:8403653
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2009
-
负责人:Jonathan D. Licht
-
依托单位:
国内基金
海外基金
增生性玻璃体视网膜病变早期钙黏蛋白(Cadherins)异常表达启动视网膜色素上皮细胞游离的分子机制
-
批准号:81770939
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:王方
-
依托单位:
Beta-catenin/Cadherins, EphBs 在平衡颅神经嵴细胞的粘附和迁徙机制的研究
-
批准号:81400494
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:刘人恺
-
依托单位:
Cadherins与nectins在青少年期慢性社会应激损害小鼠前额叶形态可塑性与功能中的作用
-
批准号:81401129
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:李继涛
-
依托单位: